THRN - הכנסה לפני ניכוי ריבית, מסים ופחת Thorne HealthTech, Inc.

Thorne HealthTech (THRN) is scaling its digital ecosystem and nutraceutical product line following a change in ownership structure. The business is implementing AI platforms for biomarker analysis, automating routine clinic operations. Cash EBITDA dynamics confirm financial trends, where represents the current metric. Growth is supported by L Catterton investments, the development of genetic tests, and demand for wellness products among athletes.

Operating cash flow dynamics determine the fundamental value of the asset, allowing investors to assess the real efficiency of the business before deducting financial and tax obligations. The EBITDA_Co valuation analysis captures daily net inflows, reflecting how the scalable digital subscription and personalized testing platform of Thorne HealthTech (THRN) converts customer loyalty into stable cash growth.